Neglected tropical diseases: progress towards addressing the chronic pandemic

The Lancet

Volumn 389, Issue 10066, 2017, Pages 312-325

  Molyneux, David H ^a   Savioli, Lorenzo ^b   Engels, Dirk ^c  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b Chavannes de Bogis   (Switzerland)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; COMORBIDITY; DRACUNCULIASIS; DRUG INDUSTRY; EPILEPSY; GLOBAL DISEASE BURDEN; HEALTH INSURANCE; HELMINTHIASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYGIENE; LEPROSY; LYMPHATIC FILARIASIS; MALIGNANT NEOPLASM; ONCHOCERCIASIS; PANDEMIC; PRIORITY JOURNAL; RESEARCH PRIORITY; REVIEW; SANITATION; SCABIES; SCALE UP; SCHISTOSOMIASIS; SUSTAINABLE DEVELOPMENT; SYSTEMATIC REVIEW (TOPIC); TRACHOMA; TROPICAL DISEASE; TRYPANOSOMIASIS; VECTOR CONTROL; YAWS; INTERNATIONAL COOPERATION; NEGLECTED DISEASE; PUBLIC HEALTH SERVICE; RESEARCH; TROPICAL MEDICINE;

CHRONIC DISEASE; HUMANS; INTERNATIONAL COOPERATION; NEGLECTED DISEASES; PANDEMICS; PUBLIC HEALTH PRACTICE; RESEARCH; TROPICAL MEDICINE;

EID: 84994713411     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)30171-4     Document Type: Review

References (80)

1. 1 Liese, B, Rosenberg, M, Schratz, A, Programmes, partnerships, and governance for elimination and control of neglected tropical diseases. Lancet 375 (2010), 67–76.
2. 2 Gyapong, JO, Gyapong, M, Yellu, N, et al. Integration of neglected tropical diseases into health care challenges and opportunities. Lancet 375 (2010), 1–6.
3. 3 Baker, MC, Mathieu, E, Fleming, FM, et al. Mapping, monitoring, and surveillance of neglected tropical diseases: towards a policy framework. Lancet 375 (2010), 231–238.
4. 4 Conteh, L, Engels, T, Molyneux, DH, Socioeconomic aspects of neglected tropical diseases. Lancet 375 (2010), 239–247.
5. 5 Hotez, PJ, Fenwick, A, Savioli, L, Molyneux, DH, Rescuing the bottom billion through control of neglected tropical diseases. Lancet 373 (2009), 1570–1575.
6. 6 World Health Organization. Investing to overcome the global impact of neglected tropical diseases: WHO third report on neglected tropical diseases, 2015, WHO, Geneva https://www.yumpu.com/en/document/view/37074971/1a9bnbk/5 (accessed Sept 1, 2015).
7. 7 Liese, BL, Houghton, N, Teplitskaya, L, Development assistance for neglected tropical diseases: progress since 2009. Int Health 6 (2014), 162–171.
8. 8 London Declaration on Neglected Tropical Diseases. Uniting to Combat NTDs. http://unitingtocombatntds.org/sites/default/files/document/london_declaration_on_ntds.pdf (accessed May 5, 2016).
9. 9 World Health Assembly. Neglected tropical diseases Prevention, control, elimination and eradication. World Health Assembly, 66, 2013, 12.
10. 10 World Health Organization. A Roadmap for Implementation: accelerating work to overcome the global impact of neglected tropical diseases 2012, 2012, WHO, Geneva http://www.who.int/neglected_diseases/NTD_RoadMap_2012_Fullversion.pdf (accessed April 15, 2015).
11. 11 United Nations. A new global partnership: eradicate poverty and transform economies through sustainable development. The Report of the High-Level Panel of Eminent Persons on the Post-2015 Development Agenda, 2013, United Nations Publications, New York.
12. 12 The Global Fund. Sustainable development goal document UN 33rd. Meeting of the Board of the Global Fund Framework for financing co-infections and co-morbidities of HIV/AIDS, tuberculosis and malaria, 2016, Global Fund, Geneva http://www.theglobalfund.org/en/board/decisions/ (accessed June 5, 2016).
13. 13 G7 Germany. Leader's declaration, G7 Summit, 7–8 June, 2015. https://www.g7germany.de/Content/DE/_Anlagen/G8_G20/2015-06-08-g7-abschluss-eng.pdf?__blob=publicationFile&v=5 (accessed July 10, 2015).
14. 14 Hotez, PJ, Blue Marble Health Redux: Neglected Tropical Diseases and Human Development in the Group of 20 (G20) Nations and Nigeria. PLoS Negl Trop Dis, 8, 2015, e0004035.
15. 15 Engels, D, Neglected tropical diseases in the Sustainable Development Goals. Lancet 387 (2016), 223–234.
16. 16 Cross, C, Olamiju, F, Richards, F, Bush, S, Hopkins, A, Haddad, D, Historical profiles and perspectives from river blindness to neglected tropical diseases—lessons learned in Africa for programme implementation and expansion by the non-governmental partners. PLoS Negl Trop Dis, 10, 2015, 371.
17. 17 Murray, CJ, Vos, T, Lozano, R, Naghavi, M, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet 380 (2012), 2197–2223.
18. 18 Hotez, PJ, Alvarado, M, Basáñez, M-G, et al. The Global Burden of Disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Negl Trop Dis, 7, 2014, e2865.
19. 19 King, CH, Bertino, AM, Asymmetries of poverty: why global burden of disease valuations underestimate the burden of neglected tropical diseases. PLoS Negl Trop Dis, 2, 2008, e209.
20. 20 Ton, T, Mackenzie, CD, Molyneux, DH, The burden of mental health in lymphatic filariasis. Infect Dis Pov 30 (2015), 4–34.
21. 21 Ndeffo Mbah, ML, Kjetland, EF, Atkins, KE, et al. Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa. Proc Natl Acad Sci USA 110 (2013), 7952–7957.
22. 22 Olveda, RM, Acosta, LP, Tallo, V, et al. Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 16 (2016), 199–208.
23. 23 Bhattarai, R, Budke, CM, Carabin, H, et al. Estimating the non-monetary burden of neurocysticercosis in Mexico. PLoS Negl Trop Dis, 6, 2012, e1521.
24. 24 Fürst, T, Keiser, J, Utzinger, J, Global Burden of food borne trematodiasis: a systematic review and meta analysis. Lancet Infect Dis 12 (2012), 210–221.
25. 25 Khaled, H, Schistosomiasis and cancer in Egypt: review. J Adv Res, 4, 2013, 4616.
26. 26 UNICEF UNDP World Bank, WHO. For research on diseases of poverty. http://www.who.int/tdr/publications/year/2012/en/, 2012 (accessed July 27, 2016).
27. 27 Hadinegoro, SR, Arredondo-García, JL, Capeding, MR, et al., for the CYD-TDV Dengue Vaccine Working Group. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N Engl J Med 373 (2015), 1195–1206.
28. 28 Utzinger, J, Keiser, J, Shuhua, X, Tanner, M, Singer, BH, Combination chemotherapy of Schistosomiasis in laboratory studies and clinical trials. Antimicrob Agents Chemother 47 (2003), 1487–1495.
29. 29 Allen, T, Parker, M, Will increased funding for neglected tropical diseases really make poverty history?. Lancet 379 (2012), 1097–1098.
30. 30 Chami, GF, Kontoleon, A, Bulte, E, et al. Profiling nonrecipients of mass drug administration for schistosomiasis and hookworm infections: a comprehensive analysis of praziquantel and albendazole coverage in community-directed treatment in Uganda. Clin Inf Dis 62 (2016), 200–207.
31. 31 Molyneux, DH, Hopkins, A, Bradley, MH, Kelly-Hope, L, Multidimensional complexities of filariasis control in an era of large-scale mass drug administration programmes: a can of worms. Parasit Vectors 4 (2014), 1756–3305.
32. 32 Ngoumou, P, Walsh, JF, Mace, JM, A rapid mapping technique for the prevalence and distribution of onchocerciasis: a Cameroon case study. Ann Trop Med Parasitol 88 (1994), 463–474.
33. 33 Zouré, HG, Wanji, S, Noma, M, et al. The geographic distribution of Loa loa in Africa: results of large-scale implementation of the rapid assessment procedure for loiasis (RAPLOA). PLoS Negl Trop Dis, 5, 2011, e1210.
34. 34 Gyapong, JO, Kyelem, D, Kleinschmidt, I, et al. The use of spatial analysis in mapping the distribution of bancroftian filariasis in four West African countries. Ann Trop Med Parasitol 96 (2002), 695–705.
35. 35 Sightsavers. Global Trachoma Mapping Project. www.sightsavers.org/trachoma-mapping-project-identifies-100-million-people-at-risk-from-blindness/ (accessed Aug 1, 2016).
36. 36 Simarro, PP, Cecchi, G, Franco, JR, et al. Estimating and mapping the population at risk of sleeping sickness. PLoS Negl Trop Dis, 6, 2012, e1859.
37. 37 Sime, H, Deribe, K, Assefa, A, et al. Integrated mapping of lymphatic filariasis and podoconiosis; lessons learnt from Ethiopia. Parasit Vectors 27 (2014), 7–397.
38. 38 World Health Organization. Progress towards eliminating onchocerciasis in the WHO Region of the Americas: verification by WHO of elimination of transmission in Colombia. Wkly Epidemiol Rec 88 (2013), 381–388.
39. 39 Thomsen, EK, Sanuku, N, Baea, M, et al. Efficacy, safety, and pharmacokinetics of coadministered diethylcarbamazine, albendazole, and ivermectin for treatment of Bancroftian Filariasis. Clin Infect Dis 62 (2016), 334–341.
40. 40 Hemingway, J, Ranson, J, Magill, A, et al. Averting a malaria disaster: will insecticide resistance derail malaria control?. Lancet 387 (2016), 1785–1788.
41. 41 Taylor-Robinson, DC, Maayan, N, Soares-Weiser, K, Donegan, S, Garner, P, Deworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin, and school performance. Cochrane Database Syst Rev, 23, 2015, 7.
42. 42 World Health Organization. Advisory body upholds continued deworming of children against soil-transmitted helminthiases, 2015, WHO, Geneva http://www.who.int/neglected_diseases/news/update-deworming-children/en/cochrane (accessed Jan 4, 2016).
43. 43 Stoltzfus, RJ, Chwaya, HM, Tielsch, J, Schulze, KJ, Albonico, M, Savioli, L, Epidemiology of iron deficiency anaemia in Zanzibari schoolchildren: the importance of hookworms. Am. J Clin Nut 65 (1997), 153–159.
44. 44 The Carter Center. Guinea worm wrap-up. No 242. https://www.cartercenter.org/news/publications/health/guinea_worm_wrapup_english.html, Jan 2016 (accessed July 27, 2016).
45. 45 Eberhard, ML, Ruiz-Tiben, E, Hopkins, DR, et al. The peculiar epidemiology of Dracunculiasis in Chad. Am J Trop Med Hyg 13 (2013), 61–70.
46. 46 World Health Organization. Report of a WHO Expert Committee on Control and surveillance of human African Trypanosomiasis. Technical Report Series, 2013, WHO, Geneva http://apps.who.int/iris/bitstream/10665/95732/1/9789241209847_eng.pdf?ua=1 (accessed Jan 4, 2016).
47. 47 Tirados, I, Esterhuizen, J, Kovacic, V, et al. Tsetse control and Gambian sleeping sickness; implications for control strategy. PLoS Negl Trop Dis, 12, 2015, e0003822.
48. 48 Morillo, CA, Marin-Neto, JA, Avezum, A, et al. Randomized trial of Benznidazole for chronic Chagas' cardiomyopathy. N Engl J Med 373 (2015), 1295–1306.
49. 49 World Health Organization. Global leprosy: update on the 2012 situation. Wkly Epidemiol Rec 88 (2013), 365–380.
50. 50 World Health Organization. Global programme to eliminate lymphatic filariasis: progress report 2014. Wkly Epidemiol Rec 90 (2015), 489–504.
51. 51 Rebollo, MP, Sambou, SM, Thomas, B, et al. Elimination of lymphatic filariasis in Gambia. PLoS Negl Trop Dis, 18, 2015, e0003642.
52. 52 Ramaiah, KD, Ottesen, EA, Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease. PLOS Negl Trop Dis, 11, 2014, e3319.
53. 53 Weil, G, Curtis, KC, Fakoli, L, et al. Laboratory and field evaluation of a new rapid test for detecting Wuchereria bancrofti antigen in human blood. Am J Trop Med Hyg 89 (2013), 11–15.
54. 54 Rodríguez-Pérez, MA, Fernández-Santos, NA, Orozco-Algarra, ME, et al. Elimination of Onchocerciasis from Mexico. PLoS Negl Trop Dis, 9, 2015, e0003922.
55. 55 Roungou, JB, Yameogo, L, Mwikisa, C, Boakye, DA, Bundy, A, 40 years of the APOC partnership. PLOS Negl Trop Dis, 9, 2015, e0003562.
56. 56 Romani, L, Whitfeld, MJ, Koroivueta, J, et al. Mass drug administration for scabies in a population with endemic disease. N Engl J Med 373 (2015), 2305–2313.
57. 57 World Health Organization. World Health Assembly Resolution WHA 65.21 Elimination of schistosomiasis, 2012, WHO, Geneva http://www.who.int/neglected_diseases/mediacentre/WHA_65.21_Eng.pdf (accessed April 9, 2016).
58. 58 World Health Organization. World Health Assembly Resolution WHA 54.19 Elimination of schistosomiasis, 2001, WHO, Geneva http://www.who.int/neglected_diseases/mediacentre/WHA_54.19_Eng.pdf (accessed April 9, 2016).
59. 59 Trastullo, R, Dolci, LS, Passerini, N, Albertini, B, Development of flexible and dispersible oral formulations containing praziquantel for potential schistosomiasis treatment of pre-school age children. Int J Pharm 495 (2015), 536–550.
60. 60 World Health Organization. Schistosomiasis: number of people receiving preventive chemotherapy in 2012. Wkly Epidemiol Rec 89 (2014), 21–28.
61. 61 Anderson, RM, Turner, HC, Truscott, JE, Hollingsworth, TD, Brooker, SJ, Should the goal for the treatment of soil transmitted helminth (STH) infections be changed from morbidity control in children to community-wide transmission elimination?. PLoS Negl Trop Dis, 9, 2015, e0003897.
62. 62 World Health Organization. Water Sanitation & Hygiene for accelerating and sustaining progress on Neglected Tropical Diseases – a global strategy 2015-2020, 2015, WHO, Geneva http://apps.who.int/iris/bitstream/10665/182735/1/WHO_FWC_WSH_15.12_eng.pdf?ua=1 (accessed Sept 4, 2016).
63. 63 Solomon, A, Optimising the management of trachomatous trichiasis. Lancet Glob Health 4 (2016), e140–e141.
64. 64 Marks, M, Mitjà, O, Vestergaard, LS, et al. Challenges and key research questions for yaws eradication. Lancet Infect Dis 15 (2015), 1220–1225.
65. 65 World Health Organization. Eradication of yaws in India. Wkly EpidemiolRec 90 (2015), 161–168.
66. 66 Molyneux, DH, ‘Neglected’ diseases but unrecognised successes—challenges and opportunities for infectious disease control. Lancet 364 (2004), 380–383.
67. 67 Welburn, SC, Beange, I, Ducrotoy, MJ, Okello, AL, The neglected zoonoses— the case for integrated control and advocacy. Clin Microbiol Infect 21 (2015), 433–443.
68. 68 Bhatt, S, Gething, PW, Brady, OJ, et al. The global distribution and burden of dengue. Nature 4496 (2013), 504–507.
69. 69 World Health Organization. Chikungunya. Fact Sheet No 327, 2015, WHO, Geneva http://www.who.int/mediacentre/factsheets/fs327/en/ 2015 (accessed Sept 4, 2016).
70. 70 Boissier, J, Moné, H, Mitta, G, et al. Schistosomiasis reaches Europe. Lancet Infect Dis 15 (2015), 757–758.
71. 71 Molyneux, D, Hallaj, Z, Keusch, GT, et al. Zoonoses and mariginalised infectious diseases of poverty: where do we stand?. Parasit Vectors 14 (2011), 4–106.
72. 72 World Health Organization. WHO Expert Consultation on rabies. Second report. WHO Tech Rep Ser 982 (2013), 1–139.
73. 73 Lightowlers, MW, Control of Taenia solium taeniasis/cysticercosis: past practices and new possibilities. Parasitology 140 (2013), 1566–1577.
74. 74 Mewara, A, Goyal, K, Sehgal, R, Neurocysticercosis: a disease of neglect. Trop Parasitol 3 (2013), 106–113.
75. 75 World Health Organization. World's largest deworming campaign targets 270 million children in one day, 2016, WHO, Geneva http://www.who.int/neglected_diseases/news/270_million_children_treated_in_one_day/en/ (accessed July 27, 2016).
76. 76 World Health Organization, World Bank. Tracking Universal Health Coverage: the first global monitoring report 2015, 2015, WHO, Geneva http://www.who.int/healthinfo/universal_health_coverage/report/2015/en/ (accessed April 30, 2016).
77. 77 Webster, JP, Molyneux, D, Hotez, PJ, Fenwick, A, The contribution of mass drug administration to global health—past, present and future. Philos Trans R Soc Lond B Biol Sci, 369, 2014, 20130434.
78. 78 Hollingsworth, TD, Adams, EA, Anderson, RA, et al., for the NTD Modelling Consortium. Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases. Parasit Vectors, 8, 2015, 630.
79. 79 Turner, HC, Bettis, AA, Chu, BK, et al. The health and economic benefits of the the Global programme to Eliminate Lymphatic Filariasis (2000–2014). Infect Dis Poverty, 5, 2016, 54.
80. 80 de Vlas, SJ, Stolk, WA, le Rutte, EA, et al. Concerted efforts to control or eliminate neglected tropical diseases: how much health will be gained?. PLoS Negl Trop Dis, 10, 2016, e000386.